PROOF! Tennessee Senator Bob Corker Will Be Trump’s VP
Tennessee Senator Bob Corker is rumored to be a front runner for Trump’s VP, this newest development makes it a lockRead More »
Over the past two years, a policy battle of enormous significance for the future of health care and liberty in the United States has played out in state legislatures and governor’s mansions across the country. The question: whether states will bow to President Obama’s wishes and implement his versions of health insurance exchanges – rife with bureaucratic regulations, delivery mechanisms for the whims of Kathleen Sebelius, and, of course, subsidized heavily by you the taxpayer – or whether they will resist, refusing to waste taxpayer dollars, holding out for the day when Obamacare is no more.
On one side of this battle is a small band of dedicated activists and think tank policy wonks from conservative and libertarian organizations. On the other side is the White House, the bulk of industry, most insurers, and former Bush HHS Secretary Michael Leavitt – the man who, according to Politico, is likely to become Mitt Romney’s chief of staff. He’s lobbied across the country for states to implement Obamacare exchanges, while his consultancy, Leavitt Partners, has reaped the financial benefits:
Leavitt has said some relatively positive things about certain elements of Obama’s health reform law, suggesting earlier this year that “Obamacare” empowers the HHS secretary “to do certain things that are clearly aimed at trying to move us in the right direction.”
McKeown, who still works with Leavitt at his Utah-based health care consultancy, acknowledged that the former governor does not want to undo one key part of the controversial legislation.
“We believe that the exchanges are the solution to small business insurance market and that’s gotten us sideways with some conservatives,” he said.
The exchanges are not only a matter of principle for Leavitt — they’re also a cash cow. The size of his firm, Leavitt Partners, doubled in the year after the bill was signed as they won contracts to help states set up the exchanges funded by the legislation.
Leavitt’s status as one of the few Republicans supporting Obamacare implementation has been a matter of significant concern for those on the right, as he and his consultancy represent the most prominent figures in the party urging states to bow to Washington’s wishes in this regard. I wrote about his work here, but here are a few examples:
On the day Obamacare was passed, Leavitt Partners weighed in: “There are tremendous opportunities for innovators in the market to shape how the massive legislation is implemented.” And they set about doing so, building a team to profit from the hundreds of millions of taxpayer dollars in grants sent to states to set up these exchanges. It’s a living – but the fact that Leavitt and his allies failed to note their financial stake in implementation in any of the aforementioned speeches or columns was a tendency which attracted the criticism of many in the health policy space.
Thankfully, most Republican legislatures and governors have rejected Leavitt’s approach outright. Today, there is little question that opponents of Obamacare exchange implementation have won the battle. But it is concerning that this was a battle won over the heavy opposition of someone who may end up determining Obamacare’s replacement.
For Mitt Romney’s part, his campaign reiterated his commitment to repealing the health care law when reached for comment. But this isn’t about repeal. It’s about what comes next.